2013
DOI: 10.1038/gim.2013.61
|View full text |Cite
|
Sign up to set email alerts
|

ACMG Standards and Guidelines for fragile X testing: a revision to the disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics and Genomics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
139
0
3

Year Published

2014
2014
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 129 publications
(144 citation statements)
references
References 94 publications
2
139
0
3
Order By: Relevance
“…Some studies have shown, however, that reproductive function may be significantly impacted in this range [36]; however, other studies have shown no obvious impact [22,58]. The American College of Obstetrics and Gynecology Genetics Committee, and the American College of Medical Genetics (ACMG), explicitly state that an FMR1 CGG repeat length of <45 'is not associated with an abnormal phenotype' [66]. This 'normal' range, however, may not in fact be a homogenous population.…”
Section: The Cgg Mutationsmentioning
confidence: 99%
“…Some studies have shown, however, that reproductive function may be significantly impacted in this range [36]; however, other studies have shown no obvious impact [22,58]. The American College of Obstetrics and Gynecology Genetics Committee, and the American College of Medical Genetics (ACMG), explicitly state that an FMR1 CGG repeat length of <45 'is not associated with an abnormal phenotype' [66]. This 'normal' range, however, may not in fact be a homogenous population.…”
Section: The Cgg Mutationsmentioning
confidence: 99%
“…21 Polymerase chain reaction (PCR)-based analysis was performed in all participants. PCR was performed using an untagged forward primer and a fluorescence-tagged reverse primer, as previously described.…”
Section: Cgg Repeat Analysesmentioning
confidence: 99%
“…In addition, in contrast to lymphocytes and amniocytes, the FMR1 gene is not methylated on the inactive X chromosome in the chorionic villi of female fetuses (13).…”
Section: Diagnosis Of Fxsmentioning
confidence: 99%
“…Currently, as the best practice to determine full mutation, laboratories have to use both PCR and Southern blot analysis. Consequently, in their most updated policy statement, the American College of Medical Genetics and Genomics (ACMG) recommends that Southern blot analysis always be performed along with traditional PCR (13). It is worth noting that since the current DNA analyses only tests for expansion of the CGG repeat, individuals with FXS due to missense mutations or deletions involving FMR1 have to undergo sequencing of the FMR1 gene in order to be properly diagnosed.…”
Section: Management Of Fxsmentioning
confidence: 99%